Research Team Led by Professors Seunghyun Kim and Dam Ryu at Soonchunhyang University Seoul Hospital Announces Study Results

Risk of Atrial Fibrillation Rises Up to 6.8 Times in Patients Aged 50 and Older

A new study has found that the greater the degree of liver fibrosis in patients with non-alcoholic fatty liver disease, the higher their risk of developing new arrhythmias, particularly atrial fibrillation. Among people aged 50 and older, a higher FIB-4 index—a measure of liver fibrosis—was found to be even more strongly associated with an increased risk of atrial fibrillation.


Professor Seunghyun Kim, Department of Cardiology, and Professor Dam Ryu, Department of Gastroenterology, Soonchunhyang University Seoul Hospital (left). Soonchunhyang University Seoul Hospital

Professor Seunghyun Kim, Department of Cardiology, and Professor Dam Ryu, Department of Gastroenterology, Soonchunhyang University Seoul Hospital (left). Soonchunhyang University Seoul Hospital

View original image

Soonchunhyang University Seoul Hospital announced on August 26 that the research team led by Professor Seunghyun Kim of the Department of Cardiology and Professor Dam Ryu of the Department of Gastroenterology analyzed the association between liver fibrosis and future arrhythmia among 10,263 patients with fatty liver disease, using data from Lifelines, a large-scale population-based cohort study from the Netherlands. The findings were as stated above.


The team examined the relationship between the non-invasive FIB-4 index, which indicates the degree of liver fibrosis, and new-onset arrhythmias detected by subsequent electrocardiogram examinations. Patients were divided into high and low liver fibrosis groups based on their FIB-4 scores—which take into account liver function, platelet count, and age—and the rates of new arrhythmia onset were compared between the two groups.


According to the study, patients with fatty liver disease and an FIB-4 index of 1.45 or higher had a fivefold higher risk of newly detected arrhythmias during follow-up, compared to those with an FIB-4 index below 1.45. Specifically, the risk of atrial fibrillation was 6.82 times higher. This association remained significant even after adjusting for metabolic risk factors such as diabetes, hypertension, and dyslipidemia.


When broken down by age, patients aged 50 and above with high FIB-4 indices had approximately 2.7 times greater risk of developing atrial fibrillation, a difference that remained statistically significant even after adjusting for major metabolic risk factors. The overall risk of developing arrhythmia also tended to be about twice as high. In contrast, among patients under 50, there were no cases of newly developed arrhythmias during the follow-up period, even among those with high liver fibrosis scores.


Professor Seunghyun Kim commented, "Through this study, we have confirmed that liver fibrosis is an indicator not only of the prognosis of liver disease itself but also of the risk of arrhythmia development," adding, "An integrated approach that considers the progression of liver disease as well as the risk of arrhythmias, including atrial fibrillation, is needed when caring for patients with non-alcoholic fatty liver disease."


Professor Dam Ryu stated, "This research confirmed the close connection between liver health and heart health," and emphasized, "For patients aged 50 and above with fatty liver disease and high liver fibrosis scores, regular monitoring for arrhythmias should be considered."



The paper by Professors Seunghyun Kim and Dam Ryu's research team was published in the international journal 'Scientific Reports' in May.


This content was produced with the assistance of AI translation services.

© The Asia Business Daily. All rights reserved. Unauthorized AI training and use prohibited.

Today’s Briefing